Cargando…
A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer
Bladder cancer (BC) is the most common malignancy of the urinary system. Pyroptosis is a host programmed cell death. However, the effects of pyroptosis-related lncRNAs (PRLs) on BC have not yet been completely elucidated. In this study, a prognostic PRLs model and two ceRNA networks were established...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393225/ https://www.ncbi.nlm.nih.gov/pubmed/36003338 http://dx.doi.org/10.3389/fgene.2022.936305 |
_version_ | 1784771224049549312 |
---|---|
author | Mo, Xiaocong Hu, Di Li, Yin Nai, Aitao Ma, Feng Bashir, Shoaib Jia, Guoxia Xu, Meng |
author_facet | Mo, Xiaocong Hu, Di Li, Yin Nai, Aitao Ma, Feng Bashir, Shoaib Jia, Guoxia Xu, Meng |
author_sort | Mo, Xiaocong |
collection | PubMed |
description | Bladder cancer (BC) is the most common malignancy of the urinary system. Pyroptosis is a host programmed cell death. However, the effects of pyroptosis-related lncRNAs (PRLs) on BC have not yet been completely elucidated. In this study, a prognostic PRLs model and two ceRNA networks were established using sufficient bioinformatics analysis and preliminary RT-qPCR validation in vitro. 6 PRLs were identified to construct a prognostic model. Then, the prognostic model risk score was verified to be an effective independent factor (Training cohort: Univariate analysis: HR = 1.786, 95% Cl = 1.416-2.252, p < 0.001; multivariate analysis: HR = 1.664, 95% Cl = 1.308-2.116, p < 0.001; testing cohort: Univariate analysis: HR = 1.268, 95% Cl = 1.144-1.405, p < 0.001; multivariate analysis: HR = 1.141, 95% Cl = 1.018-1.280, p = 0.024). Moreover, ROC and nomogram were performed to assess the accuracy of this signature (1-year-AUC = 0.764, 3-years-AUC = 0.769, 5-years-AUC = 0.738). Consequently, we evaluated the survival curves of these 6 lncRNAs using Kaplan–Meier survival analysis, demonstrating that MAFG-DT was risk lncRNA, while OCIAD1-AS1, SLC25A25-AS1, SNHG18, PSMB8-AS1 and TRM31-AS1 were protective lncRNAs. We found a strong correlation between PRLs and tumor immune microenvironment by Pearson’s correlation analysis. As for sensitivity of anti-tumor drugs, the high-risk group was more sensitive to Sorafenib, Bicalutamide and Cisplatin, while the low-risk group was more sensitive to AKT.inhibitor.VIII, Salubrinal and Lenalidomide, etc. Meanwhile, we identified lncRNA OCIAD1-AS1/miR-141-3p/GPM6B and lncRNA OCIAD1-AS1/miR-200a-3p/AKAP11 regulatory axes, which may play a potential role in the progression of BC. |
format | Online Article Text |
id | pubmed-9393225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93932252022-08-23 A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer Mo, Xiaocong Hu, Di Li, Yin Nai, Aitao Ma, Feng Bashir, Shoaib Jia, Guoxia Xu, Meng Front Genet Genetics Bladder cancer (BC) is the most common malignancy of the urinary system. Pyroptosis is a host programmed cell death. However, the effects of pyroptosis-related lncRNAs (PRLs) on BC have not yet been completely elucidated. In this study, a prognostic PRLs model and two ceRNA networks were established using sufficient bioinformatics analysis and preliminary RT-qPCR validation in vitro. 6 PRLs were identified to construct a prognostic model. Then, the prognostic model risk score was verified to be an effective independent factor (Training cohort: Univariate analysis: HR = 1.786, 95% Cl = 1.416-2.252, p < 0.001; multivariate analysis: HR = 1.664, 95% Cl = 1.308-2.116, p < 0.001; testing cohort: Univariate analysis: HR = 1.268, 95% Cl = 1.144-1.405, p < 0.001; multivariate analysis: HR = 1.141, 95% Cl = 1.018-1.280, p = 0.024). Moreover, ROC and nomogram were performed to assess the accuracy of this signature (1-year-AUC = 0.764, 3-years-AUC = 0.769, 5-years-AUC = 0.738). Consequently, we evaluated the survival curves of these 6 lncRNAs using Kaplan–Meier survival analysis, demonstrating that MAFG-DT was risk lncRNA, while OCIAD1-AS1, SLC25A25-AS1, SNHG18, PSMB8-AS1 and TRM31-AS1 were protective lncRNAs. We found a strong correlation between PRLs and tumor immune microenvironment by Pearson’s correlation analysis. As for sensitivity of anti-tumor drugs, the high-risk group was more sensitive to Sorafenib, Bicalutamide and Cisplatin, while the low-risk group was more sensitive to AKT.inhibitor.VIII, Salubrinal and Lenalidomide, etc. Meanwhile, we identified lncRNA OCIAD1-AS1/miR-141-3p/GPM6B and lncRNA OCIAD1-AS1/miR-200a-3p/AKAP11 regulatory axes, which may play a potential role in the progression of BC. Frontiers Media S.A. 2022-08-08 /pmc/articles/PMC9393225/ /pubmed/36003338 http://dx.doi.org/10.3389/fgene.2022.936305 Text en Copyright © 2022 Mo, Hu, Li, Nai, Ma, Bashir, Jia and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Mo, Xiaocong Hu, Di Li, Yin Nai, Aitao Ma, Feng Bashir, Shoaib Jia, Guoxia Xu, Meng A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer |
title | A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer |
title_full | A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer |
title_fullStr | A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer |
title_full_unstemmed | A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer |
title_short | A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer |
title_sort | novel pyroptosis-related prognostic lncrnas signature, tumor immune microenvironment and the associated regulation axes in bladder cancer |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393225/ https://www.ncbi.nlm.nih.gov/pubmed/36003338 http://dx.doi.org/10.3389/fgene.2022.936305 |
work_keys_str_mv | AT moxiaocong anovelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT hudi anovelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT liyin anovelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT naiaitao anovelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT mafeng anovelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT bashirshoaib anovelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT jiaguoxia anovelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT xumeng anovelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT moxiaocong novelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT hudi novelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT liyin novelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT naiaitao novelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT mafeng novelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT bashirshoaib novelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT jiaguoxia novelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer AT xumeng novelpyroptosisrelatedprognosticlncrnassignaturetumorimmunemicroenvironmentandtheassociatedregulationaxesinbladdercancer |